Stimulant and SSRI Medication Trends in ADHD

Prescription trends for stimulants, selective serotonin reuptake inhibitors (SSRI), and combination therapies for ADHD, comorbid and emotional disorders were evaluated by a retrospective population-based analysis of North Carolina Medicaid prescription claim files for the years 1992-1998.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2001-06-01
Series:Pediatric Neurology Briefs
Subjects:
Online Access:https://www.pediatricneurologybriefs.com/articles/1745